Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM ... Indigo Diabetes, Dexcom, and Roche. Hirsh had conducted research for Dexcom, Tandem, and Mannkind, and ...

The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early ...

Roche has launched what it says is a first-of-its-kind handheld glucose management ... CardioSignal for monitoring cardiac rhythms, and SteadySense's continuous temperature measurement tool ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...

Through this collaboration, Glucotrack will leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its Continuous Blood Glucose ...